![](https://endpts.com/wp-content/uploads/2020/01/epn-peer-review@x2.jpg)
With GlaxoSmithKline in the rearview mirror, Abbas Hussain is ready to lead a biotech of his own; Doug Treco scores first CEO job since Ra Pharma buyout
→ Abbas Hussain was once considered to be a top candidate to take Andrew Witty’s place as CEO of GlaxoSmithKline in 2016. When the job …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.